Cytovale, Inc.

SOUTH SAN FRANCISCO, CA 94080

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $3.71MM
First Award Date 01/01/13
Most Recent Award Date 07/01/17

Key Personnel

Last Name Name Awards Contact
Tse Henry Tse 3
Gossett Daniel R. Gossett 4 Message
Gossett Daniel R Gossett 2 Message
SHAH AJAY SHAH 2

9 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-14-011
Budget: 07/01/17 - 06/30/18
PI: AJAY SHAH

Project Summary Sepsis, an uncontrolled systemic inflammatory immune response to local infection by bacteria or fungi, is responsible for more deaths than prostate cancer, breast cancer, and AIDS combined, accounts for more than 40% of ICU costs, and is the most expensive inpatient condition in the U.S. (~$20B in annual U.S. healthcare expenditu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-14-011
Budget: 09/01/16 - 06/30/17
PI: AJAY SHAH

Project Summary Sepsis, an uncontrolled systemic inflammatory immune response to local infection by bacteria or fungi, is responsible for more deaths than prostate cancer, breast cancer, and AIDS combined, accounts for more than 40% of ICU costs, and is the most expensive inpatient condition in the U.S. (~$20B in annual U.S. healthcare expenditu...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 07/01/15 - 06/30/16
PI: Henry Tse

DESCRIPTION (provided by applicant): The rise in using companion diagnostics to guide selection of pharmacological agents in cancer treatment has led to a need for technologies which can extend these diagnostics to additional patients with difficult to access tumors. Such diagnostic assays are performed on cells extracted from tumors or metastat...

Phase 2 SBIR

Agency: National Science Foundation
Topic: BC
Budget: 11/26/14 - 11/30/16

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is in detecting sepsis early in its course, before end organ damage when it is most treatable. Sepsis, an uncontrolled systemic response to local infection by bacteria or fungi, is responsible for more deaths than prostate cancer, breast ca...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 08/01/14 - 07/31/15
PI: Henry Tse

DESCRIPTION (provided by applicant): There has been increased interest in using mechanical properties of cells as label-free biomarkers for applications in basic biology and clinical diagnostics. Increased single-cell deformability has been correlated with malignancy in cell lines and patient samples for example. In contrast to conventional mole...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-14-011
Budget: 08/01/14 - 01/31/15

DESCRIPTION (provided by applicant): Sepsis, an uncontrolled systemic inflammatory immune response to local infection by bacteria or fungi, is responsible for more deaths than prostate cancer, breast cancer, and AIDS combined, accounts for more than 40% of ICU costs, and is the most expensive inpatient condition in the U.S. (~$20B in annual U.S....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-335
Budget: 07/10/14 - 06/30/15

DESCRIPTION (provided by applicant): The rise in using companion diagnostics to guide selection of pharmacological agents in cancer treatment has led to a need for technologies which can extend these diagnostics to additional patients with difficult to access tumors. Such diagnostic assays are performed on cells extracted from tumors or metastat...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 08/01/13 - 07/31/14
PI: Henry Tse

DESCRIPTION (provided by applicant): There has been increased interest in using mechanical properties of cells as label-free biomarkers for applications in basic biology and clinical diagnostics. Increased single-cell deformability has been correlated with malignancy in cell lines and patient samples for example. In contrast to conventional mole...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BC-2012
Budget: 01/01/13 - 12/31/13

This Small Business Innovation Research (SBIR) Phase I project will address the challenge of integrating two powerful single-cell analysis tools with the aim of developing and validating new biomarkers for malignancy. The deformability of invasive cells has long been hypothesized to confer their ability to migrate through tight tissue barriers a...